Why in news?
Scientists have identified a protein called Piezo1 in bone marrow stem cells that acts as a sensor for mechanical force. When activated, it prompts stem cells to become bone‑forming cells. The finding could lead to drugs that mimic the benefits of exercise for people at risk of osteoporosis.
Background
Osteoporosis is a condition in which bones become brittle and fragile due to a loss of bone density. It affects millions worldwide, especially post‑menopausal women and older adults. Bone tissue is constantly remodeled through the opposing activities of osteoblasts (which build bone) and osteoclasts (which break down bone). Exercise strengthens bones by stimulating osteoblast activity.
New research findings
- Researchers discovered that the Piezo1 ion channel in bone marrow mesenchymal stem cells responds to mechanical stimuli. When cells experience compression or stretching (as during exercise), Piezo1 opens and triggers a cascade that leads the cells to differentiate into osteoblasts.
- In mice, deleting the gene encoding Piezo1 reduced bone mass and increased fat in bone marrow. This suggests that Piezo1 is essential for maintaining bone health.
- The researchers propose that activating Piezo1 pharmacologically could mimic the effect of exercise. However, because the protein is also present in other organs, any therapy must be targeted to avoid side effects.
Implications for osteoporosis management
Understanding how Piezo1 senses mechanical force could open the door to novel treatments for osteoporosis and other bone disorders. Such therapies might benefit individuals who are unable to exercise due to injury or illness. The discovery also reinforces the importance of regular physical activity and weight‑bearing exercises in maintaining bone strength.
Source: ScienceAlert
